A Study of the Safety and Effectiveness of Experimental Uproleselan With Chemotherapy for Acute Myeloid Leukemia (blood cancer)
Acute Myeloid Leukemia AML Relapsed AML Refractory AML Leukemia Leukemia, Myeloid Leukemia, Myeloid, Acute Uproleselan Uproleselan (GMI-1271)
Lead Scientists at UC Health
- Matthew Wieduwilt, MD, PhD (ucsd)
Associate Clinical Professor, Medicine. Authored (or co-authored) 25 research publications. Research interests: Acute lymphoblastic leukemia (ALL) · Acute myeloid leukemia (AML) · Bone marrow transplant · Clinical trial design and conduct.
- Gary Schiller, MD (ucla)
Professor-in-Residence, Medicine. Authored (or co-authored) 74 research publications.
- Brian Jonas, MD (ucdavis)
Associate Professor, Hematology and Oncology. Authored (or co-authored) 48 research publications.
- accepting new patients
- Start Date
- Completion Date
- GlycoMimetics Incorporated
- Phase 3
- Study Type
- Last Updated